Device Trial Radar · NCT00578994
A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System
Last checked: Nov 20, 2026Latest source record: Apr 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
388
Actual
Start
Mar 2006
Primary completion
Dec 31, 2019
Study completion Mar 31, 2021
Sponsor
- Lead sponsor
- Biomet Orthopedics, LLCPublic (ZBH)
- Sponsor type
- Industry
- First posted
- Dec 21, 2007
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in the United States.
Conditions
- Osteoarthritis
- Avascular Necrosis
Interventions
Oxford® Meniscal Unicompartmental Knee SystemDevice
Oxford® Meniscal Unicompartmental Knee System is a medial, unicompartmental knee prosthesis containing three components: a femoral component, a tibial component, and a tibial meniscal bearing.
Primary outcomes
What the sponsor says the trial is designed to measure.
- SurvivorshipTime frame: Annually for 9 years post-op
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Barrington Orthopedic Specialissts
Schaumburg, Illinois
Joint Implant Surgeons
New Albany, Ohio
Mid-South Orthopedic Associates
Cordova, Tennessee
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.